Indian Breast Cancer Therapeutics Market Cancer


  • Type: Oncology area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1225

  • Format: PPT, PDF

Indian Breast Cancer Therapeutics Market: Segmented by therapy, cancer type, distribution channel – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 1225 Categories: ,

Report Overview

Indian Breast Cancer therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

According to the National Cancer Registry Programme (NCRP) estimates that the number of cancer cases is likely to increase from 13.9 lakh in 2020 to 15.7 lakh by 2025, an increase of nearly 20%.In India, younger women are affected (average age 40-42yrs) as compared to an average age of 55-60 years in the west. Hence, awareness of breast cancer, its symptoms, early detection, regular self-breast examination, the importance of early diagnosis and prompt treatment remains essential. Out of all the types of cancers, breast cancer has become a major health concern across Indian cities, especially in the metropolitan cities like Delhi, Bengaluru, and Chennai as it accounts for more than a fourth of all female cancers. Breast cancer is a disease of very high mortality. More than 50,000 women die of breast cancer every year in India. In Indian women, breast cancer is the second most common cancer, next only to carcinoma cervix in many urban areas. The annual percentage change in the incidence ranged from 0.46 to 2.56 for breast cancer. About 35% of HER2-positive patients reported recurrence in an average duration of 36 months, 25.88% of patients diagnosed with HER2-negative showed recurrences in an average duration of 48.8 months.

Market Driving Factors

Increase in prevalence of Breast cancer, growth in awareness about the availability of cancer treatments, growing healthcare spending for cancer and technologically advancement in therapeutics are predominantly driving the market growth. The advancement of cancer drug research owing to targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical, and biotechnology companies engaged in developing cancer drugs. Above this, the higher cost involved in new drug development along with adverse effects associated with anti-cancer drug therapies are is rising the growth of the Breast Cancer drug market in India.

1. Indian Breast Cancer Therapeutics Market Overview……………………………..
A. Market Size
2. Market Driving Factors……………………….…………………………….………….
A. Rising prevalence of Breast cancer
B. Growing healthcare spending for cancer
C. Launch of technologically advanced therapeutics
3. Breast Cancer Stages………………………………………………………………
A. Stage 0
B. Stage 1
C. Stage 2
D. Stage 3
E. Stage 4
4. Breast Cancer Therapeutics Market Segmentation……………………………….
A. By Therapy
a. Chemotherapy
b. Hormone therapy
c. Targeted therapy
d. Radiation therapy
e. Surgery
B. By Cancer Type
a. Ductal Carcinoma in Situ (DCIS)
b. Invasive Ductal Carcinoma (IDC)
c. Lobular Carcinoma in Situ (LCIS)
d. Triple Negative Breast Cancer
e. Inflammatory Breast Cancer
f. Metastatic Breast Cancer
g. Breast Cancer During Pregnancy
C. By Distribution Channel
a. Hospital pharmacies
b. Ambulatory Surgical Centres
c. Retail and Online pharmacies
5. Breast Cancer Major Products Market Share……………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Novartis India – Zometa Company overview, Product & Services, Strategies & Financials
B. Novartis (Biochemie), Company overview, Product & Services, Strategies & Financials
C. Biocon Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Breast Cancer market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapy:

Indian breast cancer therapeutics market is segmented into further parts based on type of therapies as Chemotherapy, Hormone therapy, Targeted therapy, Radiation therapy and Surgery. The CAB is a machine-learning–based proteomic risk classifier. It combines 5 biomarkers (CD44, ABCC4, ABCC11, N-cadherin, and pan-cadherin) through IHC and 3 clinicopathologic parameters. The 5- and 10-year actuarial overall survival (OS) was 87% and 77% and disease-free survival (DFS) was 76% and 68%, respectively. Actuarial 5-year local and locoregional control rates were 91% and 87%, respectively, with good-to-excellent cosmesis in 78% of the women. The frequency of LRR with or without distant metastases was 8.5% and distant metastases were in 18.7% of the patients.

By Cancer Type:

Based on the cancer type, Indian Breast Cancer market is segmented into the Ductal carcinoma in situ (DCIS), Invasive Ductal Carcinoma(IDC) which is most common type of breast cancer, making up nearly 70- 80% of all breast cancer diagnoses, Lobular Carcinoma In Situ (LCIS), Triple Negative Breast Cancer, which has three most common types of receptors known to fuel most breast cancer growth–estrogen, progesterone, and the HER-2/neu gene– are not present in the cancer tumor,  Inflammatory Breast Cancer, Metastatic Breast Cancer, Breast Cancer During Pregnancy.

By Distribution Channel:

Indian Breast Cancer market can also be segmented based on type of distribution channel as Hospital pharmacies, Ambulatory Surgical Centres, Retail pharmacies, online pharmacies. The hospital pharmacies segment is projected to account for a higher share because of the dependency of patients on these pharmacies for the administration of therapies, such as chemotherapy. RGCIRC is one of the top hospitals in India to treat breast cancer. The average cost of treatment is between INR 5 to 6 lakhs, including radiotherapy, surgery and investigations. With targeted therapy, the six cycles of chemotherapy may cost you more than INR 20 lakh.

Major Players

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market. Novartis India – Zometa, Novartis (Biochemie), Biocon, Pfizer, AstraZeneca, Alkem, Roche Bristol, Sanofi Aventis, GSK are the major players in Breast Cancer Market in India. Emcure Pharmaceuticals  as launched generic metastatic breast cancer treatment drug under the brand name ‘Eribilin’ in India. Novartis Oncology is the second best anti-cancer medicine pharma company with the growth rate of XX%. Johnson & Johnson- Janssen Pharma rapidly expanding with 19% growth rate. Celgene, Pharmacyclincs, Healthkind Labs Pvt. Ltd, Arlak Biotech are other well- known players of breast cancer market in India.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements